Suppr超能文献

血液透析滤过与在线内源性液体再输注以及低通量聚砜碳酸氢盐常规血液透析中的胱抑素C、β2-微球蛋白和C反应蛋白

[Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].

作者信息

Cristofano C, Vernaglione L, Perniola M A, Lo Barco C, Muscogiuri P, Chimienti S

机构信息

S.C. di Nefrologia e Dialisi, Ospedale M. Giannuzzi, Manduria, Taranto.

出版信息

G Ital Nefrol. 2004 Nov-Dec;21 Suppl 30:S197-200.

Abstract

PURPOSE

Dialysis morbidity results partly from middle and large molecule retention, which is poorly removed by conventional hemodialysis (HD). The potential benefit of convective treatments could be the enhanced toxin removal over a wide molecular weight spectrum. This study aimed to evaluate cystatin C (cis), beta2-microglobulin (beta2-m) and C-reactive protein (CRP) removal behavior during hemodiafiltration reinfusion vs conventional low-flux HD (1.8 m2 low-flux polysulphone) (bicarbonate dialysis (BD)). The molecular weights of the substances evaluated in this study were as follows: cis = 13,300 daltons, beta2-m = 11,818 daltons, CRP = 160,000 daltons.

METHODS

Twelve patients on stable HD (six males, six females), were enrolled; six patients underwent BD and six patients underwent HFR. We measured arteriovenous serum cis, beta2-m and CRP levels, in three consecutive mid-week sessions at the following periods: pre/post-dialysis and after 60 min from the beginning of the session. At 60, 120 and 180 min of HFR, we collected the ultrafiltrate for cis, beta2-m, and CRP evaluation.

RESULTS

Cis, beta2-m and CRP mean values did not differ at pre-dialysis in the two groups. Pre/post- dialysis difference for cis in HFR vs BD was statistically significant (p=0.002) because cis reduced in HFR and increased in BD during the session. Beta2-m and CRP pre/post- dialysis differences in HFR vs BD were not significant. Cis clearance, measured 60 min after the beginning of the session was 34.2 +/- 20.1 mL/min in HFR and 24.8 +/- 18.4 mL/min in BD (p<0.05). beta2-m and CRP clearances did not differ among the treatments. Regarding the ultrafitrate concentrations during the HFR session, cis significantly decreased (2.5 +/- 0.6 mg/dL at 60 min and 2.0 +/- 0.4 mg/dL at 180 min; p=0.004), as well as beta2-m (21.5 +/- 12.9 mg/dL and 19.0 +/- 14.1 mg/dL, respectively; p=0.02). Ultrafiltrate CRP values, as expected, did not differ during HFR.

CONCLUSIONS

This study demonstrated that cis, a middle molecule, is well depurated in HFR, while in BD it increases. Beta2-m, although better removed in the convective phase during HFR, does not demonstrate a removal difference in HFR and in BD. CRP, a large molecule, does not have significant removal. Since cis and beta2-m have almost the same molecular weight, why do they have a different depuration? We need further studies to evaluate if membranes can remove these molecules or if protein electrical charges or their stereoscopy enables their removal.

摘要

目的

透析并发症部分源于中大分子物质潴留,而传统血液透析(HD)对其清除效果不佳。对流治疗的潜在益处可能是能在较宽分子量范围内增强毒素清除。本研究旨在评估血液透析滤过再输注与传统低通量HD(1.8 m²低通量聚砜膜)(碳酸氢盐透析(BD))过程中胱抑素C(Cys)、β2微球蛋白(β2-m)和C反应蛋白(CRP)的清除行为。本研究中评估物质的分子量如下:Cys = 13,300道尔顿,β2-m = 11,818道尔顿,CRP = 160,000道尔顿。

方法

纳入12例稳定HD患者(6例男性,6例女性);6例患者接受BD,6例患者接受高流量血液滤过(HFR)。我们在连续三个周三的透析时段测量动静脉血清Cys、β2-m和CRP水平,测量时间点如下:透析前/后以及透析开始60分钟后。在HFR的60、120和180分钟时,我们收集超滤液用于Cys、β2-m和CRP评估。

结果

两组透析前Cys、β2-m和CRP平均值无差异。HFR组与BD组透析前/后Cys差异具有统计学意义(p = 0.002),因为在透析过程中HFR组Cys降低而BD组升高。HFR组与BD组透析前/后β2-m和CRP差异无统计学意义。透析开始60分钟时测量的Cys清除率在HFR组为34.2±20.1 mL/分钟,在BD组为24.8±18.4 mL/分钟(p<0.05)。β2-m和CRP清除率在各治疗组间无差异。关于HFR过程中超滤液浓度,Cys显著降低(60分钟时为2.5±0.6 mg/dL,180分钟时为2.0±0.4 mg/dL;p = 0.004),β2-m也降低(分别为为21.5±12.9 mg/dL和19.0±14.1 mg/dL;p = 0.02)。正如预期,HFR过程中超滤液CRP值无差异。

结论

本研究表明,中分子物质Cys在HFR中清除良好,而在BD中升高。β2-m虽然在HFR的对流阶段清除较好,但在HFR和BD中清除差异不明显。大分子物质CRP清除不显著。由于Cys和β2-m分子量几乎相同,为何它们的清除情况不同?我们需要进一步研究来评估是膜能清除这些分子,还是蛋白质电荷或其立体结构使其得以清除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验